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I.   Executive Summary and Overall Evaluation 
 
The 2015 Dust Risk Standing Review Panel (from here on referred to as the SRP) participated in 
a WebEx/teleconference with members of the Space Human Factors and Habitability (SHFH) 
Element, representatives from the Human Research Program (HRP), NASA Headquarters, and 
the NASA Research and Education Support Services (NRESS) on November 12, 2015 (list of 
participants is in Section VII of this report).  The SRP reviewed the updated research plan for 
The Risk of Adverse Health and Performance Effects of Celestial Dust Exposure (from here on 
referred to as the Dust Risk), as well as the Evidence Report for this Risk. 
 
Overall, the SRP was very pleased with the progress made on the Dust Risk. 
 
II. Critique of Gaps and Tasks for the Risk of Adverse Health and 
Performance Effects of Celestial Dust Exposure 
 
A. Have the proper Gaps been identified to mitigate the Risk? 
a. Are all the Gaps relevant? 
b. Are any Gaps missing? 
B. Have the gap targets for closure been stated in such a way that they are measureable and closeable? 
a. Is the research strategy appropriate to close the Gaps? 
C. Have the proper Tasks been identified to fill the Gaps? 
a. Are the Tasks relevant? 
b. Are there any additional research areas or approaches that should be considered? 
c. If a Task is completed, please comment on whether the findings contribute to addressing or 
closing the Gap. 
D. If a Gap has been closed, does the rationale for Gap closure provide the appropriate evidence to support 
the closure? 
 
Gaps and Tasks: 
 The SRP thinks the Gaps are relevant and appropriate to mitigate the Risk. 
 The SRP thinks there may be one missing Gap; specifically the concern for long-term 
pulmonary health effects is still an issue, given the physical-chemical similarities of lunar 
dust to fibrosis-inducing agents such as quartz.  Therefore, the potential for fibrosis in 
extraterrestrial dust exposures on extended missions was considered by some SRP 
members to be a missing research Gap. 
 The SRP thinks the stated Gaps are measureable and closeable with the possible 
exception of the exposure guideline permissible exposure limit (PEL) Gap. 
 Although the stated Gaps appear to be measurable and closeable (with the exception of 
Gap AEH 5), one member of the SRP was concerned that because the Gaps were 
developed over time, they have become somewhat jumbled or overlapping in their 
presentation in the Report and this hinders the SRP in determining if the research strategy 
will result in measureable progress or closeable solutions for all Gaps. 
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 The SRP thinks the tasks are relevant but are mostly very general. 
 In terms of an additional Risk, one member of the SRP suggested that an elementary 
gavage study may be warranted since it is likely that these inhaled and deposited dusts 
will be cleared by the lung to the gastrointestinal (GI) tract.  Whether this might occur in 
chronic celestial dust exposure scenarios is unclear at this time. 
 The SRP thinks the tasks associated with understanding Lunar Dust Toxicity (Lunar Dust 
D/O - Cellular Studies to Support Pulmonary Toxicology Evaluation of Lunar Dust; 
Dermal Studies of Lunar Dust and Ocular Studies of Lunar Dust; Lunar Dust-ITI - 
Pulmonary Toxicity Studies of Lunar Dust in Mice and Rats;  Lunar Dust - Cell - Study 
of Lunar Dust and Lunar Simulant Activation, Monitoring; Solution and Cellular 
Toxicity Properties; and, Human Lung Low g - Clearance of Particles Depositing in the 
Human Lung in Low-Gravity) contribute substantially to the understanding of the 
toxicity of extraterrestrial dusts by establishing a theoretical framework for toxicological 
assessment. 
 The SRP thinks the Lunar Airborne Dust Toxicity Assessment Group (LADTAG) final 
report of February 7, 2014 provides the appropriate evidence to support the closure of the 
Lunar Dust Toxicity Gaps (with the exception of Gap AEH 5). 
 
AEH 1: What are the unique properties of lunar dust that affect physiology? (Closed) 
 
Tasks: 
 Geology, Geochemistry and Lithology Science Support Activities  – Completed Task 
 Study of Lunar Dust and Lunar Simulant Activation, Monitoring, Solution and Cellular 
Toxicity Properties – Completed Task 
 
AEH 2: What is the toxicity of lunar dust in the respiratory system? (Closed) 
 
Tasks: 
 Cellular Studies to Support Pulmonary Toxicology Evaluation of Lunar Dust, Dermal 
Studies of Lunar Dust and Ocular Studies of Lunar Dust – Completed Task 
 Pulmonary Toxicity Studies of Lunar Dust in Mice and Rats – Completed Task 
 Study of Lunar Dust and Lunar Simulant Activation, Monitoring, Solution and Cellular 
Toxicity Properties – Completed Task 
 Clearance of Particles Depositing in the Human Lung in Low-Gravity – Completed Task 
 
AEH 4: What is the dermal and ocular toxicity of lunar dust? (Closed) 
 
Tasks: 
 Cellular Studies to Support Pulmonary Toxicology Evaluation of Lunar Dust, Dermal 
Studies of Lunar Dust and Ocular Studies of Lunar Dust – Completed Task 
 
AEH 5: What are the permissible exposure limits for inhalation of lunar dust? (Closed) 
 The SRP does not think the rationale for closing this Gap provides the appropriate 
evidence to support the closure.  The setting of exposure guidelines is a fluid process as 
new data (e.g., newly discovered immune, cardiovascular, or fibrotic effects) become 
available.  While it is understood that a PEL is necessary to devise and build engineering 
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controls in a mission that is several years in the future, it is important to reconsider PELs 
as new data are presented.  Regardless, the SRP does not think this Gap should be closed.   
 One member of the SRP felt that particle deposition is a Gap which is considered as a 
modifier of effect, but it is not clear if the impact of modifiers such as physiologic stress, 
health status (including hydration for example), changes in ambient air quality (fractional 
gas content), and patterns of exposure (e.g., peak vs monotonic exposure levels) should 
be included in the standard PEL approach. 
 
Tasks: 
 Cellular Studies to Support Pulmonary Toxicology Evaluation of Lunar Dust, Dermal 
Studies of Lunar Dust and Ocular Studies of Lunar Dust – Completed Task 
 Geology, Geochemistry and Lithology Science Support Activities – Completed Task 
 LADTAG Lunar Dust Health Standard – Completed Task 
 Pulmonary Toxicity Studies of Lunar Dust in Mice and Rats – Completed Task 
 Study of Lunar Dust and Lunar Simulant Activation, Monitoring, Solution and Cellular 
Toxicity Properties – Completed Task 
 Clearance of Particles Depositing in the Human Lung in Low-Gravity – Completed Task 
 Extraterrestrial dust – Carbonaceous Asteroids – Deleted Task 
 
DUST 11: What is the potential for acute toxicity of lunar dust (all relevant endpoints), and 
acute/chronic cardiovascular toxicity of lunar dust? (Formerly AEH 11) 
 The SRP thinks this Gap is relevant and appropriate. 
 
Task: 
 Acute Lunar Dust Toxicology – Planned Task 
 
AEH Watch Item/NSBRI Research: What are the effects of lunar gravity on permissible 
exposure limits for inhalation of lunar dust? (Closed) 
 
Tasks: 
 Aerosol Deposition in the Lung in Fractional Gravity: Risk Mitigation for Lunar and 
Martian Habitats – Completed Task 
 Clearance of Particles Depositing in the Human Lung in Low-Gravity – Completed Task 
 Variability in flow distribution within the lung and its effects on deposition and clearance 
of inhaled particles in normal and reduced gravity (NSBRI Postdoctoral Fellowship) – 
Completed Task 
 
DUST 12: We need to determine if technologies are available or need to be developed to 
evaluate celestial dust toxicity and/or volatile composition in situ. 
 This SRP thinks this Gap is relevant but some of the tasks are unclear. 
 
Tasks: 
 Robotic Precursor – Planned Task 
o The SRP thinks that this task may be important but that it should be outsourced to 
extramural researchers.  Such high-through put systems are useful if there are 
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hundreds or thousands of samples which does not apply to existing or future 
extraterrestrial dust samples.  These high throughput systems remain largely 
invalidated given their infancy in development.  They are expensive to develop 
and while they may be worth pursuing, there is no level of confidence yet 
regarding their utility in risk quantification decision trees for a limited number of 
celestial dusts. 
 Organ on a chip (Pilot) – Planned Task 
o The SRP thinks this task is a clever approach for toxicity testing, but is beyond 
the scope of NASA at this time.  This is a rapidly developing field and while a 
comparison of single cell to organ-like cell combinations/interactions is important 
in identifying and ranking the toxicity of celestial dust samples, it would best be 
left to extramural research efforts. 
o If these models mature, it will be relatively easy and less expensive to use them at 
that time.  The approach of organ on a chip has some advantages over the more 
simple high-throughput methodology in that they do encompass an additional 
level of physiologic reality with multiple pathways and cell-cell interactions.  On 
a practical note, the SRP thinks it is also important to consider the fact that most 
of these systems are designed for water- or media-soluble testing materials 
whereas particles pose special challenges which add to the complexity of their 
use. 
 
DUST 13: We need to determine if there are significant differences in respiratory, 
cardiovascular, ocular, or dermal toxicity of dusts from different exploration targets or if 
existing permissible exposure limits can be applied. 
 The SRP thinks this Gap is relevant.  Although in a formative stage, the issues noted are 
indeed important and the SRP agrees that NASA should be examining cardiorespiratory 
and ocular/dermal impacts as well as pulmonary effects.  With assessments of existing 
knowledge of Apollo reports etc., additional toxicological work would be proposed on an 
as-needed basis.  Among the issues which would seem to be particularly relevant would 
be dose-response and patterned exposures – short or long term – that may play into the 
toxicologic risk. 
 The task of in vivo exposure studies has allowed the PEL Gap to be closed but it should 
be re-considered for additional endpoints, if necessary, as outlined in Dust 13. 
 
Tasks: 
 Celestial Dust Ground – Planned Task 
 Dust Data Mining – Planned Task 
 Martian Dust Technical Interchange Meeting (TIM) – Planned Task 
 
DUST 14: If relative toxicity is unknown and/or significant differences in toxicity do exist, 
we need to understand the acute and chronic toxicities of the celestial dust and/or volatiles 
in order to establish permissible exposure limit. 
 The SRP thinks this Gap is relevant and appropriate. 
 
No Tasks 
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III. Discussion on the strengths and weaknesses of the IRP and identify 
remedies for the weaknesses, including answering these questions: 
 
A. Is the Risk addressed in a comprehensive manner? 
 The Risk was presented in a comprehensive manner, although one member of the 
SRP suggested that the Risk could be addressed in an even more comprehensive 
manner if the Gaps were better defined/stated. 
 
B. Are there areas of integration across HRP disciplines that are not addressed that 
would better address the Risk? 
 Based on the materials presented, it is evident to the SRP that certain 
combinations of exposure appear to present the possibility of synergistic effects.  
The effect of prolonged lower gravity environments (Section 4.3.6 of the Human 
Research Program Integrated Research Plan) on celestial dust exposure is cited as 
posing potential allergenic problems that may be exacerbated by spaceflight.  
Several recent studies have provided evidence of immune dysregulation during 
spaceflight (Mehta et al., 2007, 2013; Crucian et al., 2008, 2009, 2011, 2013), 
which may show an increased potential for resulting acute hypersensitivity.  
Potentially higher radiation exposure (Sections 4.5.2 and 4.5.3), both alone or in 
combination with lower gravity environments may also effect the immune system 
when there is an exposure to Martian dust as mentioned in Gap Dust-11 and the 
two should therefore be considered as possibly synergistic.  Therefore, the SRP 
thinks the dust discipline should consider more integration with the Exploration 
Medical Capability Element, the Human Health Countermeasures Element (the 
design of the EVA suit to be more easily cleaned without producing exposure and 
reduced radiation exposure which could in turn reduce immunological function; 
the cardiovascular discipline, due to the acute cardiovascular risk from dust), and 
the Space Radiation Element. 
 The SRP thinks the dust discipline should also collaborate with other disciplines 
in the Space Human Factors and Habitability Element.  Specifically, the Space 
Human Factors Engineering Project can address measures to reduce dust intrusion 
into living areas through design of the living area, design of entry and exit 
procedures. 
 
IV. Evaluation of the progress on the Dust Risk Research Plan since the 
2014 SRP meeting 
 The SRP is pleased with the progress on the Dust Risk Research plan since it was 
presented to the Advanced Environmental Health/Advanced Food Technology SRP 
during the 2014 WebEx/teleconference. 
 
V. Additional Comments 
 Developing the ability to amend or better adapt dust control procedures is another 
unrecognized countermeasure necessary to assure that the human crew receives the 
maximum protection.  This is particularly true in case the toxicology underestimates 
the risk of a ‘new’ celestial dust or if engineered dust controls are not as effective as 
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presumed.  Therefore, dust monitoring would seem to be advisable for both airborne 
and dermal exposure situations as part of the ground station and for the return trip for 
the capsule environment.  Also, reducing dust intrusion into living areas through 
design of the living area, re-design of entry and exit procedures, and the design of the 
extravehicular activity (EVA) suit to be more easily cleaned (without generating 
additional particle exposures or reducing radiation protection) could in turn reduce 
adverse pulmonary and ocular effects. 
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VI. 2015 Dust Risk SRP Research Plan Review: Statement of Task for the 
Risk of Adverse Health and Performance Effects of Celestial Dust 
Exposure 
 
The 2015 Dust Risk Standing Review Panel (SRP) is chartered by the Human Research Program 
(HRP) Chief Scientist.  The purpose of the SRP is to review the Risk of Adverse Health & 
Performance Effects of Celestial Dust Exposure section of the current version of the HRP’s 
Integrated Research Plan (IRP) which is located on the Human Research Roadmap (HRR) 
website (http://humanresearchroadmap.nasa.gov/).  Your report, addressing each of the questions 
in the charge below and any addendum questions, will be provided to the HRP Chief Scientist 
and will also be made available on the HRR website. 
 
The 2015 Dust Risk SRP is charged (to the fullest extent practicable) to: 
1. Based on the information provided in the current version of the HRP’s IRP, evaluate the 
ability of the IRP to satisfactorily make progress in mitigating the Risk by answering the 
following questions: 
 
A. Have the proper Gaps been identified to mitigate the Risk? 
i) Are all the Gaps relevant? 
ii) Are any Gaps missing? 
 
B. Have the gap targets for closure been stated in such a way that they are measureable 
and closeable? 
i) Is the research strategy appropriate to close the Gaps? 
 
C. Have the proper Tasks been identified to fill the Gaps? 
i) Are the Tasks relevant? 
ii) Are there any additional research areas or approaches that should be considered? 
iii) If a Task is completed, please comment on whether the findings contribute to 
addressing or closing the Gap. 
 
D. If a Gap has been closed, does the rationale for Gap closure provide the appropriate 
evidence to support the closure? 
 
2. Identify the strengths and weaknesses of the IRP, and identify remedies for the weaknesses, 
including, but not limited to, answering these questions: 
A. Is the Risk addressed in a comprehensive manner? 
B. Are there areas of integration across HRP disciplines that are not addressed that would 
better address the Risk? 
C. Other 
 
3. Based on the updates provided by the Element, please evaluate the progress in the research 
plan since the last SRP meeting. 
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4. Please comment on any important issues that are not covered in #1, #2, or #3 above, that the 
SRP would like to bring to the attention of the HRP Chief Scientist and/or the Element.   
 
Additional Information Regarding This Review: 
 
1. Expect to receive review materials at least four weeks prior to the WebEx conference call.   
 
2. Participate in a WebEx conference call on November 12, 2015 at 11:30 am ET. 
A. Discuss the 2015 Dust Risk SRP Statement of Task and address questions about the SRP 
process. 
B. Receive presentations from the HRP Chief Scientist (or his designee), the Space Human 
Factors and Habitability (SHFH) Element, and participate in a question and answer 
session, and briefing. 
 
3. Prepare a draft final report (approximately one month after the WebEx conference call) that 
contains a detailed evaluation of the current IRP specifically addressing items #1, #2, and #3 
of the SRP charge.  The draft final report will be sent to the HRP Chief Scientist and he will 
forward it to the appropriate Element for their review.  The SHFH Element and the HRP 
Chief Scientist will review the draft final report and identify any misunderstandings or errors 
of fact and then provide official feedback to the SRP within two weeks of receipt of the draft 
report.  If any misunderstandings or errors of fact are identified, the SRP will be requested to 
address them and finalize the 2015 SRP Final Report as quickly as possible.  The 2015 SRP 
Final Report will be submitted to the HRP Chief Scientist and copies will be provided to the 
SHFH Element that sponsors the dust discipline and also made available to the other HRP 
Elements.  The 2015 SRP Final Report will be made available on the HRR website 
(http://humanresearchroadmap.nasa.gov/). 
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VII. Dust Risk SRP Research Plan Review WebEx/Teleconference 
Participants 
 
SRP Members: 
Terry Gordon, Ph.D. (Chair) – New York University School of Medicine 
Dan Costa, Sc.D., DABT – EPA/ORD 
Howard Kipen, M.D., M.P.H. – Rutgers University, Rutgers School of Public Health 
Michael McCawley, Ph.D. – West Virginia University 
 
NASA Johnson Space Center (JSC): 
Jennifer Fogarty, Ph.D. 
Torin McCoy, Ph.D. 
Cherie Oubre, Ph.D. 
Heather Paul 
Michele Perchonok, Ph.D. 
Gary Riccio, Ph.D. 
Jennifer Rochlis, Ph.D. 
Valerie Ryder, Ph.D. 
Robert Scully, Ph.D. 
Susan Steinberg, Ph.D. 
Mihriban Whitmore, Ph.D. 
 
NASA Headquarters (HQ): 
Steve Davison, Ph.D. 
Bruce Hather, Ph.D. 
 
NASA Research and Education Support Services (NRESS): 
Tiffin Ross-Shepard 
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VIII. 2015 Dust Risk Standing Review Roster 
 
Panel Chair: 
Terry Gordon, Ph.D. 
New York University School of Medicine 
57 Old Forge Road 
Tuxedo, NY 10987 
Ph: 845-731-3536  
Email: terry.gordon@nyumc.org 
 
Panel Members: 
Dan Costa, Sc.D., DABT 
EPA/ORD  
Air Climate & Energy Research 
D143-01    
Research Triangle Park, NC 27711 
Ph:  919-541-2532 
Email: Costa.Dan@epa.gov   
 
Howard Kipen, M.D., M.P.H. 
Rutgers University - Rutgers School of Public Health 
Division of Clinical Research and Occupational Medicine 
Environmental and Occupational Health Sciences Institute 
170 Frelinghuysen Road 
Piscataway, NJ 08854 
Phone: 848-445-6091 
Email: kipen@eohsi.rutgers.edu  
 
Michael McCawley, Ph.D.  
West Virginia University  
Department of Occupational and Environmental Health 
School of Public Health 
PO Box 9190 
Morgantown, WV 26506-9190 
Ph:  304-293-8042 
Email: mamccawley@hsc.wvu.edu  
 
 
